Insulet Corp (PODD), a US-based medical device company, Thursday reported financial report for the second quarter of 2025, ended June 30, 2025.
The company reported net income of $22.5 million, or $0.32 per share in the three month period, a significant decrease from $188.6 million, or $2.59 per share during the same period last year.
Net income fell sharply in the second of 2025 primarily due to two non-operational factors: an \$84.4 million loss on extinguishment of debt related to paying off or restructuring debt, compared to no such loss in the prior year, and the absence of an unusually high $137.5 million income tax benefit recorded in Q2 2024, with the current quarter instead reflecting a $5.9 million tax expense. Despite stronger revenue, margins, and operating income, these one-time debt and tax impacts significantly reduced reported net income year-over-year.
PODD reported adjusted net income of $83.7 million, or $1.17 per share in the second quarter of 2025, a significant increase fromm $38.3 million, or $0.55 per diluted share in the same quarter last year.
The company reported operating income of $121.1 million in the quarter, a significant increase from $54.5 during the same quarter last year.
PODD reported net sales of $649.1 million in the second quarter, an increase from $488.5 in the same quarter last year.
Thursday PODD closed at $303.55 or 9.47% higher on the NasdaqGS.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.